348 related articles for article (PubMed ID: 9482878)
1. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
Song S; Gulliver GA; Lambert PF
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
[TBL] [Abstract][Full Text] [Related]
2. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
3. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.
Balsitis S; Dick F; Lee D; Farrell L; Hyde RK; Griep AE; Dyson N; Lambert PF
J Virol; 2005 Sep; 79(17):11392-402. PubMed ID: 16103190
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
Slebos RJ; Lee MH; Plunkett BS; Kessis TD; Williams BO; Jacks T; Hedrick L; Kastan MB; Cho KR
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5320-4. PubMed ID: 8202487
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
[TBL] [Abstract][Full Text] [Related]
6. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice.
Gulliver GA; Herber RL; Liem A; Lambert PF
J Virol; 1997 Aug; 71(8):5905-14. PubMed ID: 9223480
[TBL] [Abstract][Full Text] [Related]
7. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
8. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP.
Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF
Oncogene; 2007 May; 26(23):3321-8. PubMed ID: 17130828
[TBL] [Abstract][Full Text] [Related]
9. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
Pan H; Griep AE
Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
[TBL] [Abstract][Full Text] [Related]
10. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.
Yang JT; Liu CZ; Domer P; Iannaccone P
Cancer Detect Prev; 1998; 22(5):405-15. PubMed ID: 9727621
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
Jones DL; Münger K
J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
[TBL] [Abstract][Full Text] [Related]
12. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.
Park JW; Shin MK; Lambert PF
Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229
[TBL] [Abstract][Full Text] [Related]
13. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice.
Lambert PF; Pan H; Pitot HC; Liem A; Jackson M; Griep AE
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5583-7. PubMed ID: 8390671
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
15. Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.
Balsitis SJ; Sage J; Duensing S; Münger K; Jacks T; Lambert PF
Mol Cell Biol; 2003 Dec; 23(24):9094-103. PubMed ID: 14645521
[TBL] [Abstract][Full Text] [Related]
16. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
17. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.
Butz K; Geisen C; Ullmann A; Spitkovsky D; Hoppe-Seyler F
Int J Cancer; 1996 Nov; 68(4):506-13. PubMed ID: 8945623
[TBL] [Abstract][Full Text] [Related]
18. E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice.
Schaeffer AJ; Nguyen M; Liem A; Lee D; Montagna C; Lambert PF; Ried T; Difilippantonio MJ
Cancer Res; 2004 Jan; 64(2):538-46. PubMed ID: 14744767
[TBL] [Abstract][Full Text] [Related]
19. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development.
Pan H; Griep AE
Genes Dev; 1995 Sep; 9(17):2157-69. PubMed ID: 7657167
[TBL] [Abstract][Full Text] [Related]
20. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
